In addition, the company issued to the investors, warrants to purchase 1.28 million shares of common stock at an exercise price of $0.65 per share.
Tony Shum, chairman of Cardima, said: “This transaction strengthens our balance sheet and allows the excellent team of professionals at Cardima to continue to advance our commercialization and regulatory strategies worldwide.”